Novartis AG ADR (NYSE: NVS) is -1.95% lower on its value in year-to-date trading and has touched a low of $76.90 and a high of $108.78 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVS stock was last observed hovering at around $99.77 in the last trading session, with the day’s loss setting it -0.77%.
Currently trading at $99.00, the stock is -2.47% and -4.75% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.92 million and changing -0.77% at the moment leaves the stock 1.18% off its SMA200. NVS registered 28.20% gain for a year compared to 6-month gain of 3.94%. The firm has a 50-day simple moving average (SMA 50) of $4.62 and a 200-day simple moving average (SMA200) of $11.80.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -1.52% loss in the last 1 month and extending the period to 3 months gives it a 1.77%, and is -3.55% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.98% over the week and 0.91% over the month.
Novartis AG ADR (NVS) has around 76057 employees, a market worth around $202.36B and $49.78B in sales. Current P/E ratio is 13.86 and Fwd P/E is 13.00. Profit margin for the company is 29.83%. Distance from 52-week low is 28.73% and -8.99% from its 52-week high. The company has generated returns on investments over the last 12 months (22.26%).
Novartis AG ADR quarterly earnings per share for the current quarter are estimated at $1.69 with sales reaching $11.48B over the same period.The EPS is expected to grow by 7.65% this year, but quarterly earnings will post 5.70% year-over-year. Quarterly sales are estimated to shrink -9.20% in year-over-year returns.
1,385 institutions hold shares in Novartis AG ADR (NVS), with institutional investors hold 6.95% of the company’s shares. The shares outstanding are 2.04B, and float is at 2.04B with Short Float at 0.22%. Institutions hold 6.95% of the Float.
The top institutional shareholder in the company is Dodge & Cox Inc with over 16.41 million shares valued at $1.66 billion. The investor’s holdings represent 0.72% of the NVS Shares outstanding. As of Jun 29, 2023, the second largest holder is Primecap Management Company with 15.01 million shares valued at $1.51 billion to account for 0.66% of the shares outstanding. The other top investors are Morgan Stanley which holds 7.27 million shares representing 0.32% and valued at over $733.15 million, while Loomis Sayles & Company, LP holds 0.28% of the shares totaling 6.32 million with a market value of $637.25 million.
